Prognostic factors after pneumonectomy in non-small cell lung cancer
Abstract
Background: This study aims to evaluate the factors affecting survival and mortality in patients who underwent pneumonectomy for non-small cell lung cancer.
Methods: The study included 241 pneumonectomy patients. Demographic data, mortality, histopathological characteristics, tumor stages, and 5-year survival rates were analyzed.
Results: The study included nine women (3.7%) and 232 men (96.3%). The patients’ mean age was 58.4±8.0 (34–81) years. Fortyfive patients (18.7%) were 65 years of age or older, and 196 patients (81.3%) were less than 65 years of age. The 30-day postoperative mortality rate was 7.9% (n=19). The only factor affecting mortality was determined as age 65 and over (p = 0.012). The median survival time was 52 months, and the 5-year survival rate was 49.4%. In multivariate analysis, advanced age, pN2 status, not receiving neoadjuvant treatment, performing sampling lymph node dissection, and not receiving adjuvant treatment were poor prognostic factors.
Conclusion: Age, pN2 status, neoadjuvant and adjuvant therapy, and lymph node dissection technique were determined as the most important prognostic factors affecting survival in patients who underwent pneumonectomy for non-small cell lung cancer. Age was the most important factor affecting mortality.
Keywords
Prognosis , Pneumonectomy , Survival Rate , Carcinoma , Non-Small-Cell Lung
Kaynakça
- 1. Yazgan S, Gursoy S, Ucvet A, Samancilar O, Erbaycu AE, Unal M, et al. Pneumonectomy; a risky type of resection in non-small cell lung cancer: survival and mortality analysis. Curr Thorac Surg. 2018;3(3).
- 2. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568–77.
- 3. De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(5):787–98.
- 4. Shapiro M, Swanson SJ, Wright CD, Chin C, Sheng S, Wisnivesky J, et al. Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2010;90(3):927–35.
- 5. Schneider L, Farrokhyar F, Schieman C, Shargall Y, D’Souza J, Camposilvan I, et al. Pneumonectomy: the burden of death after discharge and predictors of surgical mortality. Ann Thorac Surg. 2014;98(6):1976–82.
- 6. Kalathiya RJ, Saha SP. Pneumonectomy for non-small cell lung cancer: outcomes analysis. South Med J. 2012;105(7):350–4.
- 7. Pekçolaklar A, Nalbant M, Metin M. The factors affecting morbidity, mortality and survival in patients who underwent intrapericardial resections due to non-small cell lung cancer. Curr Thorac Surg. 6(1).
- 8. Lee M, Razi SS. Pulmonary Sleeve Resection. StatPearls [Internet]. 2020;
- 9. Cusumano G, Marra A, Lococo F, Margaritora S, Siciliani A, Maurizi G, et al. Is sleeve lobectomy comparable in terms of short- and long-term results with pneumonectomy after induction therapy? A multicenter analysis. Ann Thorac Surg. 2014;98(3):975–83.
- 10. Parissis H, Leotsinidis M, Hughes A, McGovern E, Luke D, Young V. Comparative analysis and outcomes of sleeve resection versus pneumonectomy. Asian Cardiovasc Thorac Ann. 2009;17(2):175–82.